Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9217168 Methods of cell culture

Patent 9217168 was granted and assigned to Momenta Pharmaceuticals on December, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12103960 VEGF traps and mini-traps and methods for treating ocular disorders and cancer
0
Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077570 Anti-VEGF protein compositions and methods for producing the same
0
Edits on 7 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12012444 Anti-VEGF protein compositions and methods for producing the same
0
Edits on 1 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11970724 Serum-free cell culture medium
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+160 characters)
Article

Patent abstract

Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using putrescine, are described.

Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11753459 Anti-VEGF protein compositions and methods for producing the same
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11661456 Sialylated glycoproteins
0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=092171680
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09217168 Methods of cell culture US Patent 9217168 Methods of cell culture

Infobox
Patent Number
092171680
Patent Number
92171680
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Momenta Pharmaceuticals
Momenta Pharmaceuticals
0
Current Assignee
Momenta Pharmaceuticals
Momenta Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
092171680
Date of Patent
December 22, 2015
0
Patent Application Number
138293330
Date Filed
March 14, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=092171680
Patent Primary Examiner
‌
Maury Audet
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09217168
Edits on 4 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 4 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09217168 Methods of cell culture

Infobox
Is a
Patent
Patent
Patent applicant
Momenta Pharmaceuticals
Momenta Pharmaceuticals
Current assignee
Momenta Pharmaceuticals
Momenta Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09217168
Date of patent
December 22, 2015
Patent application number
13829333
Date Filed
March 14, 2013
Patent primary examiner
‌
Maury Audet

Find more entities like US Patent 9217168 Methods of cell culture

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo